Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2513-2517

  Safranek, J ^a   Pesta, M ^a   Holubec, Lubos ^a,b   Kulda, V ^a   Dreslerova, J ^a   Vrzalova, J ^a   Topolcan, O ^a   Pesek, M ^a   Finek, J ^a   Treska, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Department of Oncology and Radiotherapy ^*  (Czech Republic)

Author keywords

MMPs; mRNA; Non small cell lung cancer; RT PCR; TIMPs; Tissue samples

Indexed keywords

GELATINASE B; MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LUNG ADENOCARCINOMA; LUNG DISEASE; LUNG EMPHYSEMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 69249187540     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pesek M: Bronchogenic carcinoma: new trends in diagnosis and therapy. Vnitr Lek 57(9): 392-394, 2005.
2. Fingleton BM, Heppner Goss KJ, Crawford HC and Matrisian LM: Matrilysin in early stage intestinal tumorigenesis. APMIS 107(1): 102-110, 1999.
3. Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10(6): 415-433, 2000. (Pubitemid 32181912)
4. Curran S and Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36(13): 1621-1630, 2000. (Pubitemid 30616366)
5. Coussens LM, Fingleton B and Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295(5564): 2387-2392, 2002. (Pubitemid 34270240)
6. Brinckerhoff CE and Matrisian LM: Matrix metalloproteinases a tail of a frog that become a prince. Nat Rev Mol Cell Biol 3(3): 207-214, 2002. (Pubitemid 37237143)
7. Bonomi P: Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol 29(1 Suppl 4): 78-86, 2002.
8. Passlick B, Sienel W, Seen-Hibler R, Wockel W, Thetter O, Mutschler W et al: Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 6: 3944-3948, 2000. (Pubitemid 30807086)
9. Yamamura T, Nakanishi K, Hiroi S, Kumaki F, Sato H, Aida S et al: Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in non-small cell lung carcinomas. Lung Cancer 35(3): 249-255, 2002. (Pubitemid 34158657)
10. Albelda S: Biology of disease role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Inv 68(1): 4-17,1993.
11. Leeman MF, Curran S and Murray GI: New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201(4): 528-534, 2003. (Pubitemid 38256401)
12. Honda M, Mori M, Ueo H, Sugimachi K and Akiyoshi T: Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 39: 444-448,1996. (Pubitemid 26338536)
13. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M and Imai K: Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59(14): 3313-3316, 1999. (Pubitemid 29334482)
14. Yamashita K, Mori M, Shiraishi T, Shibuta K and Sugimachi K: Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 6(3): 1169-1174, 2000. (Pubitemid 30159381)
15. Roeb E, Schleinkofer K, Kernebeck T, Pötsch S, Jansen B, Behrmann I, Matern S and Grötzinger J: The matrix metalloproteinase 9 (MMP-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist. J Biol Chem 277(52): 50326-50332, 2002. (Pubitemid 36042181)
16. Cox G, Jones JL and O'Byrne KJ: Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non- small cell lung cancer. Clin Cancer Res 6(6): 2349-2355, 2000. (Pubitemid 30399202)
17. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74(2): 111-122, 1997. (Pubitemid 27455388)
18. Elkington PT and Friedland JS: Matrix metalloproteinases in destructive pulmonary pathology. Thorax 61(3): 259-266, 2006.
19. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E and Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases- 1 (TIMP-I) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 29S(7): 29-32, 1992.
20. Luparello C, Avanzato G, Carella C and Pucci-Minafra I: Tissue inhibitor of metalloproteinase (TIMP)-1 and proliferative behavior of clonal breast cancer cells. Breast Cancer Res Treat 54(3): 235-244, 1999. (Pubitemid 29322346)
21. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A and Stetler-Stevenson M: In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102(11): 2002-2010, 1998.
22. Pesta M, Holubec L Jr, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J and Cerny R: Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP- 2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TTMP-1, TIMP-2) in colorectal carcinoma tissue samples. Anticancer Res 25(5): 3387-3391,2005. (Pubitemid 41105215)
23. Rydlova M, Holubec L Jr, Ludvikova M Jr, Kalfert D, Franekova J, Povysil C and Ludvikova M: Biological activity and clinical implications of the matrix metalloproteinases. Anticancer Res 28(2B): 1389-1397, 2008. (Pubitemid 351578885)
24. Ondo K, Sugio K, Yamazaki K, Yamaguchi M, Yano T, Yoshino I and Maehara Y: The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer. Lung Cancer 46(2): 205-213, 2004. (Pubitemid 39330415)
25. Junker K: Prognostic factors in stage I/II non-small cell lung cancer. Lung Cancer 33(Suppl): 17-24, 2001.
26. Baker EA and Leaper DJ: Profiles of matrix metalloproteinases and their tissue inhibitors in intraperitoneal drainage fluid: relationship to wound healing. Wound Repair Regen 11(4): 268-274, 2003. (Pubitemid 36897523)
27. Sutnar A, Pesta M, Liska V, Treska V, Skalicky T, Kormunda S, Topolcan O, Cerny R and Holubec L Jr: Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CTiA tissue samples from colorectal liver metastases. Tumour Biol 28(5): 247-252, 2007. (Pubitemid 350165830)
28. Chang TJ, Juan CC, Yin PH, Chi CW and Tsay HJ: Up- regulation of beta-actin, cyclophilin and GAPDH in NlSl rat hepatoma. Oncol Rep 5(2): 469-471, 1998.
29. Ripple MO and Wilding G: Alteration of glyceraldehyde-3- phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cells. Cancer Res 55(19): 4234-4236, 1995.
30. Tang Ch-H, Tan T-W, Fu W-M and Yang R-S: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/ CXCR4 pathway of lung cancer metastasis. Carcinogenesis 29(1): 35-43, 2008.
31. Safranek J, Holubec L, Topolcan O, Pesta M, Klecka J, Vodicka J, Finek J, Kormunda S and Pesek M: Expresion of MMP-7 mRNA and TIMP-1 mRNA in non-small cell lung cancer. Anticancer Res 27(4C): 2953-2956, 2007. (Pubitemid 47228027)